NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Oct 30, 2013

Total Value ($000): $2,523,649 (100.0% shares, 0.0% debt)

Holdings (31)

GROUPON INC 24.2%
Value ($000) $609,971 Shares 54,413,072 Est. Cost $8.55 Unrealized
TESARO INC 15.1%
Value ($000) $382,031 Shares 9,861,412 Est. Cost $32.74 Unrealized
CVENT INC 10.2%
Value ($000) $256,711 Shares 7,299,146 Est. Cost $35.17 Unrealized
EPIZYME INC 9.6%
Value ($000) $241,584 Shares 6,039,589 Est. Cost $28.13 Unrealized
XOOM CORP 6.4%
Value ($000) $160,481 Shares 5,052,935 Est. Cost $22.92 Unrealized
CLOVIS ONCOLOGY INC 5.5%
Value ($000) $138,611 Shares 2,279,781 Est. Cost $66.98 Unrealized
CHANNELADVISOR CORP 4.0%
Value ($000) $101,381 Shares 2,767,697 Est. Cost $15.73 Unrealized
FUSION-IO INC 3.7%
Value ($000) $94,244 Shares 7,038,379 Est. Cost $14.24 Unrealized
SUPN SUPERNUS PHARMACEUTICALS INC 3.1%
Value ($000) $78,065 Shares 10,650,000 Est. Cost $5.89 Unrealized +14.0%
HYPERION THERAPEUTICS INC 3.0%
Value ($000) $75,365 Shares 2,884,221 Est. Cost $22.00 Unrealized
MILLENNIAL MEDIA INC 2.3%
Value ($000) $58,149 Shares 8,224,752 Est. Cost $8.71 Unrealized
BOINGO WIRELESS INC 1.5%
Value ($000) $38,276 Shares 5,467,960 Est. Cost $6.21 Unrealized
AUDIENCE INC 1.3%
Value ($000) $32,349 Shares 2,878,005 Est. Cost $13.21 Unrealized
SUNESIS PHARMACEUTICALS INC 1.1%
Value ($000) $27,957 Shares 5,636,573 Est. Cost $5.19 Unrealized
LEXICON PHARMACEUTICALS INC 1.1%
Value ($000) $27,789 Shares 11,676,000 Est. Cost $2.17 Unrealized
TARGACEPT INC 1.0%
Value ($000) $24,283 Shares 4,572,999 Est. Cost $4.27 Unrealized
INTERMUNE INC 0.8%
Value ($000) $20,625 Shares 1,341,000 Est. Cost $9.62 Unrealized
NEKTAR THERAPEUTICS 0.8%
Value ($000) $19,078 Shares 1,825,600 Est. Cost $11.55 Unrealized
LINKEDIN CORP 0.7%
Value ($000) $18,815 Shares 76,467 Est. Cost $178.30 Unrealized
GLU MOBILE INC 0.7%
Value ($000) $16,524 Shares 5,943,793 Est. Cost $2.21 Unrealized
ZHONE TECHNOLOGIES INC 0.6%
Value ($000) $15,061 Shares 4,781,290 Est. Cost $0.80 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.5%
Value ($000) $13,115 Shares 5,653,029 Est. Cost $3.07 Unrealized -18.4%
CADENCE PHARMACEUTICALS INC 0.5%
Value ($000) $13,043 Shares 2,070,286 Est. Cost $6.82 Unrealized
EXEL EXELIXIS INC 0.5%
Value ($000) $12,845 Shares 2,207,000 Est. Cost $4.74 Unrealized +9.2%
RIGEL PHARMACEUTICALS INC 0.5%
Value ($000) $11,610 Shares 3,243,150 Est. Cost $3.34 Unrealized
ALIMERA SCIENCES INC 0.4%
Value ($000) $10,082 Shares 2,681,250 Est. Cost $4.88 Unrealized
OREXIGEN THERAPEUTICS INC 0.3%
Value ($000) $7,082 Shares 1,155,300 Est. Cost $6.13 Unrealized
TRANSCEPT PHARMACEUTICALS INC 0.3%
Value ($000) $6,636 Shares 2,086,755 Est. Cost $3.02 Unrealized
SOLTA MED INC 0.2%
Value ($000) $5,919 Shares 2,859,577 Est. Cost $2.28 Unrealized
ARQULE INC 0.2%
Value ($000) $5,872 Shares 2,520,316 Est. Cost $2.32 Unrealized
NEUROMETRIX INC 0.0%
Value ($000) $95 Shares 57,273 Est. Cost $2.01 Unrealized